Danaher 2Q'26: Yet Another "Meh" Quarter Danaher is one of those compounders that has largely lost its luster in current market. However, Danaher shareholders cannot quite blame Mr.
Danaher 1Q'26 Update Danaher had another somewhat uneventful quarter. Looking at Danaher’s numbers every quarter is a stark reminder just how anemic the growth has proved to be for a company that enjoys some supposedly secular tailwinds.
Anthropic's focused bet, Portfolio Change A programming note: As a reminder, I will take the next two days off for Thanksgiving, and hope to be back on Saturday. Happy Thanksgiving, everyone!
Some Portfolio Changes I made a few changes in my portfolio yesterday which I will discuss behind the paywall. In addition to “Daily Dose” (yes, DAILY) like this, MBI Deep Dives publishes one Deep Dive on a publicly listed company every month.
Danaher 3Q'25 Update Following Sartorius 3Q’25 call, I mentioned in my update that I am actually a bit surprised that Danaher stock didn’t react more positively.
Danaher 2Q'25 Update While S&P 500 is at its all-time high, Danaher is still ~34% below its peak from late 2021. The company was beleaguered with pandemic hangover and destocking trends for much of 2022-24 period.
Danaher: A compounding machine over four decades Steven and Mitchell Rales, the two brothers who co-founded Danaher, formed an investment partnership in 1979 when they were still in their 20s.